Literature DB >> 27667685

A Functional Role for Antibodies in Tuberculosis.

Lenette L Lu1, Amy W Chung2, Tracy R Rosebrock3, Musie Ghebremichael4, Wen Han Yu5, Patricia S Grace4, Matthew K Schoen4, Fikadu Tafesse4, Constance Martin3, Vivian Leung3, Alison E Mahan4, Magdalena Sips6, Manu P Kumar7, Jacquelynne Tedesco4, Hannah Robinson4, Elizabeth Tkachenko4, Monia Draghi4, Katherine J Freedberg4, Hendrik Streeck8, Todd J Suscovich4, Douglas A Lauffenburger7, Blanca I Restrepo9, Cheryl Day10, Sarah M Fortune11, Galit Alter12.   

Abstract

While a third of the world carries the burden of tuberculosis, disease control has been hindered by a lack of tools, including a rapid, point-of-care diagnostic and a protective vaccine. In many infectious diseases, antibodies (Abs) are powerful biomarkers and important immune mediators. However, in Mycobacterium tuberculosis (Mtb) infection, a discriminatory or protective role for humoral immunity remains unclear. Using an unbiased antibody profiling approach, we show that individuals with latent tuberculosis infection (Ltb) and active tuberculosis disease (Atb) have distinct Mtb-specific humoral responses, such that Ltb infection is associated with unique Ab Fc functional profiles, selective binding to FcγRIII, and distinct Ab glycosylation patterns. Moreover, compared to Abs from Atb, Abs from Ltb drove enhanced phagolysosomal maturation, inflammasome activation, and, most importantly, macrophage killing of intracellular Mtb. Combined, these data point to a potential role for Fc-mediated Ab effector functions, tuned via differential glycosylation, in Mtb control.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Fc-receptors; antibodies; inflammasome; innate immunity; tuberculosis

Mesh:

Substances:

Year:  2016        PMID: 27667685      PMCID: PMC5526202          DOI: 10.1016/j.cell.2016.08.072

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  92 in total

1.  Reference based annotation with GeneMapper.

Authors:  Sourav Chatterji; Lior Pachter
Journal:  Genome Biol       Date:  2006-04-05       Impact factor: 13.583

2.  Host-detrimental role of Esx-1-mediated inflammasome activation in mycobacterial infection.

Authors:  Fredric Carlsson; Janice Kim; Calin Dumitru; Kai H Barck; Richard A D Carano; Mei Sun; Lauri Diehl; Eric J Brown
Journal:  PLoS Pathog       Date:  2010-05-06       Impact factor: 6.823

3.  A mycobacterial lipoarabinomannan specific monoclonal antibody and its F(ab') fragment prolong survival of mice infected with Mycobacterium tuberculosis.

Authors:  B Hamasur; M Haile; A Pawlowski; U Schroder; G Kallenius; S B Svenson
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

4.  Susceptibility to Mycobacterium tuberculosis infection in HIV-positive patients is associated with CARD8 genetic variant.

Authors:  Alessandra Pontillo; Marcia S Carvalho; Anselmo J Kamada; Ronald Moura; Haiana C Schindler; Alberto J S Duarte; Sergio Crovella
Journal:  J Acquir Immune Defic Syndr       Date:  2013-06-01       Impact factor: 3.731

5.  Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccines.

Authors:  Amy W Chung; Musie Ghebremichael; Hannah Robinson; Eric Brown; Ickwon Choi; Sophie Lane; Anne-Sophie Dugast; Matthew K Schoen; Morgane Rolland; Todd J Suscovich; Alison E Mahan; Larry Liao; Hendrik Streeck; Charla Andrews; Supachai Rerks-Ngarm; Sorachai Nitayaphan; Mark S de Souza; Jaranit Kaewkungwal; Punnee Pitisuttithum; Donald Francis; Nelson L Michael; Jerome H Kim; Chris Bailey-Kellogg; Margaret E Ackerman; Galit Alter
Journal:  Sci Transl Med       Date:  2014-03-19       Impact factor: 17.956

6.  An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis.

Authors:  Matthew P R Berry; Christine M Graham; Finlay W McNab; Zhaohui Xu; Susannah A A Bloch; Tolu Oni; Katalin A Wilkinson; Romain Banchereau; Jason Skinner; Robert J Wilkinson; Charles Quinn; Derek Blankenship; Ranju Dhawan; John J Cush; Asuncion Mejias; Octavio Ramilo; Onn M Kon; Virginia Pascual; Jacques Banchereau; Damien Chaussabel; Anne O'Garra
Journal:  Nature       Date:  2010-08-19       Impact factor: 49.962

7.  Human gene variants linked to enhanced NLRP3 activity limit intramacrophage growth of Mycobacterium tuberculosis.

Authors:  Daniel Eklund; Amanda Welin; Henrik Andersson; Deepti Verma; Peter Söderkvist; Olle Stendahl; Eva Särndahl; Maria Lerm
Journal:  J Infect Dis       Date:  2013-10-24       Impact factor: 5.226

8.  Association of Human Antibodies to Arabinomannan With Enhanced Mycobacterial Opsonophagocytosis and Intracellular Growth Reduction.

Authors:  Tingting Chen; Caroline Blanc; Anke Z Eder; Rafael Prados-Rosales; Ana Camila Oliveira Souza; Ryung S Kim; Aharona Glatman-Freedman; Maju Joe; Yu Bai; Todd L Lowary; Rachel Tanner; Michael J Brennan; Helen A Fletcher; Helen McShane; Arturo Casadevall; Jacqueline M Achkar
Journal:  J Infect Dis       Date:  2016-04-07       Impact factor: 5.226

9.  DNA-Containing Immunocomplexes Promote Inflammasome Assembly and Release of Pyrogenic Cytokines by CD14+ CD16+ CD64high CD32low Inflammatory Monocytes from Malaria Patients.

Authors:  Isabella C Hirako; Carolina Gallego-Marin; Marco A Ataide; Warrison A Andrade; Humberto Gravina; Bruno C Rocha; Rosane B de Oliveira; Dhelio B Pereira; Joseph Vinetz; Betty Diamond; Sanjay Ram; Douglas T Golenbock; Ricardo T Gazzinelli
Journal:  mBio       Date:  2015-11-17       Impact factor: 7.867

10.  A blood RNA signature for tuberculosis disease risk: a prospective cohort study.

Authors:  Daniel E Zak; Adam Penn-Nicholson; Thomas J Scriba; Ethan Thompson; Sara Suliman; Lynn M Amon; Hassan Mahomed; Mzwandile Erasmus; Wendy Whatney; Gregory D Hussey; Deborah Abrahams; Fazlin Kafaar; Tony Hawkridge; Suzanne Verver; E Jane Hughes; Martin Ota; Jayne Sutherland; Rawleigh Howe; Hazel M Dockrell; W Henry Boom; Bonnie Thiel; Tom H M Ottenhoff; Harriet Mayanja-Kizza; Amelia C Crampin; Katrina Downing; Mark Hatherill; Joe Valvo; Smitha Shankar; Shreemanta K Parida; Stefan H E Kaufmann; Gerhard Walzl; Alan Aderem; Willem A Hanekom
Journal:  Lancet       Date:  2016-03-24       Impact factor: 79.321

View more
  201 in total

1.  Serologic Responses in Childhood Pulmonary Tuberculosis.

Authors:  Bareng A S Nonyane; Mark P Nicol; Nicholas J Andreas; Stefanie Rimmele; Nicole Schneiderhan-Marra; Lesley J Workman; Mark D Perkins; Thomas Joos; Tobias Broger; Jerrold J Ellner; David Alland; Beate Kampmann; Susan E Dorman; Heather J Zar
Journal:  Pediatr Infect Dis J       Date:  2018-01       Impact factor: 2.129

2.  HIV-antibody complexes enhance production of type I interferon by plasmacytoid dendritic cells.

Authors:  Rebecca T Veenhuis; Zachary T Freeman; Jack Korleski; Laura K Cohen; Guido Massaccesi; Alessandra Tomasi; Austin W Boesch; Margaret E Ackerman; Joseph B Margolick; Joel N Blankson; Michael A Chattergoon; Andrea L Cox
Journal:  J Clin Invest       Date:  2017-10-30       Impact factor: 14.808

Review 3.  Genetics and evolution of tuberculosis pathogenesis: New perspectives and approaches.

Authors:  Michael L McHenry; Scott M Williams; Catherine M Stein
Journal:  Infect Genet Evol       Date:  2020-01-22       Impact factor: 3.342

Review 4.  Updates on antibody functions in Mycobacterium tuberculosis infection and their relevance for developing a vaccine against tuberculosis.

Authors:  Jacqueline M Achkar; Rafael Prados-Rosales
Journal:  Curr Opin Immunol       Date:  2018-04-12       Impact factor: 7.486

5.  Antibodies: Marking disease states in tuberculosis.

Authors:  Elisabeth Kugelberg
Journal:  Nat Rev Immunol       Date:  2016-10-26       Impact factor: 53.106

Review 6.  Tuberculosis vaccines - perspectives from the NIH/NIAID Mycobacteria vaccine testing program.

Authors:  Angelo A Izzo
Journal:  Curr Opin Immunol       Date:  2017-07-24       Impact factor: 7.486

Review 7.  Targeting innate immunity for tuberculosis vaccination.

Authors:  Shabaana A Khader; Maziar Divangahi; Willem Hanekom; Philip C Hill; Markus Maeurer; Karen W Makar; Katrin D Mayer-Barber; Musa M Mhlanga; Elisa Nemes; Larry S Schlesinger; Reinout van Crevel; Raman (Krishna) Vankayalapati; Ramnik J Xavier; Mihai G Netea
Journal:  J Clin Invest       Date:  2019-09-03       Impact factor: 14.808

8.  Nanoparticle-Fusion Protein Complexes Protect against Mycobacterium tuberculosis Infection.

Authors:  Peter Hart; Alastair Copland; Gil Reynolds Diogo; Shane Harris; Ralf Spallek; Wulf Oehlmann; Mahavir Singh; Juan Basile; Martin Rottenberg; Matthew John Paul; Rajko Reljic
Journal:  Mol Ther       Date:  2017-12-22       Impact factor: 11.454

9.  Latently and uninfected healthcare workers exposed to TB make protective antibodies against Mycobacterium tuberculosis.

Authors:  Hao Li; Xing-Xing Wang; Bin Wang; Lei Fu; Guan Liu; Yu Lu; Min Cao; Hairong Huang; Babak Javid
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-24       Impact factor: 11.205

Review 10.  The Role of BAFF System Molecules in Host Response to Pathogens.

Authors:  Jiro Sakai; Mustafa Akkoyunlu
Journal:  Clin Microbiol Rev       Date:  2017-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.